Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, MicrobiomX is raising $2,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Roslyn Hendriks played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About MicrobiomX
At MicrobiomX we aim to provide a rapid, safe, reliable and non-invasive way to restore a healthy intestinal microbiome. Antibiotics and chemotherapy are the atomic bombs of modern healthcare and can damage a healthy intestinal microbiome with even a single dose. The disruption of a complex ecosystem can affect the immune system and the way food is processed in the body. Furthermore, disrupted intestinal bacteria balance has been linked to mental health disorders, obesity, malnutrition, and inflammatory diseases. The critical importance of the gut microbiome to our health has been well established, and microbiome research is continuing to shed light on the potential to improve our health through our microbiome. Hundreds of clinical trials are underway for a wide variety of medical conditions. However, existing methods for collecting and processing samples are time consuming, costly, and often invasive. Our team at MicrobiomX recognized the opportunity to develop a scalable, safe, rapid solution.

To learn more about MicrobiomX, visit http://microbiomx.com/

Contact:
Roslyn Hendriks, Chief Executive Officer
206-351-2662
https://www.linkedin.com/in/roz-brandon/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved